CAPFX
Price
$8.58
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
VWINX
Price
$26.14
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

CAPFX vs VWINX

Header iconCAPFX vs VWINX Comparison
Open Charts CAPFX vs VWINXBanner chart's image
Federated Hermes Capital Income F
Price$8.58
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Wellesley® Income I
Price$26.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CAPFX vs VWINX Comparison Chart
Loading...
VS
CAPFX vs. VWINX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPFX is a StrongBuy and VWINX is a StrongSell.

FUNDAMENTALS
Fundamentals
VWINX has more cash in the bank: 51.5B vs. CAPFX (692M). VWINX (3.38) and CAPFX (3.27) have matching dividends . CAPFX was incepted earlier than VWINX: CAPFX (28 years) vs VWINX (54 years). CAPFX (54.00) and VWINX (53.00) have comparable annual turnover. CAPFX has a lower initial minimum investment than VWINX: CAPFX (1500) vs VWINX (3000). CAPFX annual gain was more profitable for investors over the last year : 15.97 vs. VWINX (10.44). CAPFX return over 5 years is better than : 31.94 vs. VWINX (7.29).
CAPFXVWINXCAPFX / VWINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years54 years-
Gain YTD9.4757.227131%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRA250N/A-
Net Assets692M51.5B1%
Annual Yield % from dividends3.273.3897%
Returns for 1 year15.9710.44153%
Returns for 3 years7.83-6.28-125%
Returns for 5 years31.947.29438%
Returns for 10 years42.6923.63181%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVA38.540.91
+2.42%
Avista Corp
KIDS32.280.68
+2.15%
OrthoPediatrics Corp
DOC22.580.17
+0.76%
Healthpeak Properties
BRAG4.900.02
+0.41%
Bragg Gaming Group
ERNA1.50-0.03
-1.96%
Eterna Therapeutics